| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 May 24 | VIR Vir Biotechnology | Common Stock | Grant | Acquire A | No | No | 0 | 8,000 | 0.00 | 23,806 |
| 30 May 24 | VIR Vir Biotechnology | Stock Option Common Stock | Grant | Acquire A | No | No | 10.39 | 16,000 | 166.24 k | 16,000 |
| 16 May 24 | ALNY Alnylam Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 151.22 | 5,228 | 790.58 k | 5,228 |
| 8 Sep 23 | SURF Surface Oncology | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 45,453 | 0.00 | 0 |
| 8 Sep 23 | SURF Surface Oncology | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.35 | 113,636 | 39.77 k | 0 |
